Scientists are testing a new experimental drug that could halt Alzheimer’s disease before memory loss begins. The trial, run by an NHS trust as part of a global effort to prevent dementia, will enroll healthy middle‑aged adults who are identified as having a higher genetic or lifestyle risk for the disease. Participants will receive the medication under close monitoring, and researchers hope the treatment will delay or stop the progression to clinical dementia. The study reflects a growing shift toward early intervention in neurodegenerative disorders.
Healthy middle-aged people deemed to be at higher risk of developing condition among those eligible to participatePeople without memory loss will be offered an experimental Alzheimer’s drug that could stop the development of the condition before dementia symptoms emerge.Healthy middle-aged people deemed to have a higher risk of developing the condition will be eligible to participate in the trial, which is being run by an NHS trust as part of an international clinical trial aiming to prevent dementia. Continue reading...
